Skip to main content

Table 2 Gains and Losses of the regions and the genes reported to be differentiallyexpressed.

From: Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines

Cytoband

Size (Mb)

Minimal region boundary clones

Number of refseq genes in region

Reported Copy number alterations

Genes known/found to be differentially expressed

1q25.2-q31.3

17.73

174994286–192721998

68

Gogusev et al. (2002)

ANGPTL1, LHX4, PNF2, RGS1, NEK7, PCTRK3, CTSE, MYOG, RGS2

1q42.2-q43

9.16

228621517–237777167

30

Gogusev et al. (2002)

LGALS8, NID, MTR, OPN3, GNG4, TBCE

2p16.2-p13.3

17.77

53587332–70354068

63

Joos et al. (2002)

REL, PNPT1, RPS27A, XPO1, SLC1A4, MSH6, MGC15407

2q23.1-q24.2

13.83

149314143–163139362

40

current study

TNFAIP6, GCA, LY75, SLC25A12, DCL-1, ITGB6, RBMS1

2q24.2-q31.3

18.76

163139362–181903843

81

Franke et al. (2001)

MTX2, DPP4, ATP5G3, TLK1, STAT1, BBS5, SCRN3, NFE2L2

5p15.32-p14.3

10

5257164–15261389

20

current study

DNAH5, DDX4, MGC5309, ARFRP2, CTNND2, MYO10

5q14.1-q15

18.99

79623141–98609560

48

Joos et al. (2003)

C5ORF12, CACH-1, RPS23, ANKRD32, TBCA, KIAA0372, RHOBTB3

7q11.1-q36.3

97.02

61369644–158387760

575

current study

PRSS1, TRY6, PRSS2, CDK6, CLDN4, HSPB1, HGF, mTERF, ING3, TPST1

8q23.3-24.12

5.08

116154379–121233686

19

Joos et al. (2003)

MYC, RAD21, DEPDC6, THRAP6, DCC1

9p24.3-p24.1

5.9

23994–5928516

28

Joos et al. (2003)

JAK2, RANBP6, UHRF2, C9orf46, C9orf123, MLANA, RCL1, AK3L1

9p21.3-p12

14.87

25192411–40063723

119

current study

PRSS3, DNAJA1, RPS6, CCDC2

11q22.1-q23.3

19.91

98410656–118317962

106

Falzetti et al. (1999)

ATM, DDX6, CRYAB, PDGFD

12q13.13-q14.1

8.64

53812697–62450135

114

current study

DDIT3, DTX3, KRT6IRS, HOXC4, HOXC5, LEMD3, TBK1, USP15

13q12.13-q12.3

5.49

25577047–31063440

25

current study

GTF3A, MTIF3, PAN3, APRIN, BRCA2

13q13.1-q21.32

35.16

31151386–66311960

108

Joos et al. (2002)

Ufm1, C13orf1, RCBTB1, KBTBD6, NARG1L, DDX26, NUDT15

13q31.1-q34

27.91

86156309–114062150

74

Joos et al. (2002)

STK24, DCT, GPC5, DZI, EFNB2, TM9SF2, RASA3, LOC196541

16q22.1-q24.1

19.68

65582104–85259588

170

Joos et al. (2002)

CIRH1A, CKLFSF3, DNCL12, BMO39

20p12.3-q13.11

33.93

8872139–42799402

185

current study

PCNA, SNAP25, FKBP1A, SNPH, TH1L, SPAG4L, TDE1, SLC2A10, C20orf52, EYA2

20q13.2-q13.32

6.95

50997916–57946927

31

current study

TFAP2C, CDH4, ZFP64, GNAS, ATP5E

18q21.32-q23

19.03

58644127–77673453

52

current study

VPS4B, RTTN, PIGN , ZCCHC2, BCL2, FLJ25715, TXNL4A, ZNF516 , PARD6G

  1. Aligned with data from the University of California, Santa Cruz Human Browser April 2003 Freeze. Novel regions are in underlined bold. Genes in italic and underlined are those that previously been reported {Joos et al. 2003 [19]; Gogusev et al. [20]; Joos et al. 2002 [29]; Franke et al. [54]; Falzetti et al. [55]}, whereas those in bold and italic are those found to be over-expressed and down regulated, respectively, in the current study.